Get a Quote

Tag: Best Practices

Latest Articles

Rural Health Transformation Program: What the 15% Cap on Provider Payments Means for Rural Practices

Key Takeaways RHTP provider payments are capped at 15% of a state’s total award per budget period under CMS’s Category B funding rules, a restriction...

Prior Authorization for GLP-1 Medications: What Providers Need to Know

Key Takeaways GLP-1s require prior authorization because the same drug can be covered or excluded depending on the diagnosis it’s prescribed for, not the drug...

AB 1041: What California Providers and Health Plans Need to Know About the New Credentialing Law

Key Takeaways AB 1041, authored by Assemblymember Bennett, was signed into law October 11, 2025 as Chapter 630, Statutes of 2025. It amends both the...

CMS 0062: What Providers and Payers Need to Know About the Proposed Drug Prior Authorization Rule

Key Takeaways CMS 0062, formally CMS-0062-P, is a proposed rule, not a final one. CMS released it April 10, 2026, and the public comment period...

CMS 0057: What Providers Need to Know About the New Prior Authorization Rule

Key Takeaways CMS 0057 (CMS-0057-F) regulates payers, not providers, but reshapes prior authorization turnaround, denial transparency, and electronic submission for everyone who submits PA requests....

Neolytix Identifies an Average of $341K in Payer Contract Revenue Opportunities — Get Your Assessment Done Today

Free live webinar

Acquiring or merging a practice? Plan for the cash gap before it occurs.

Join Ritu Bhatnagar, Neolytix’s Founder and COO, and Chris Marchese, COO of  vybe urgent care, for Enrollment 101 for Healthcare M&A : A live playbook for payer enrollment, billing and cash flow through the deal.

Keynote Speakers

Ritu Bhatnagar
Founder and Chief Operating Officer, Neolytix
Chris Marchese
Chief Operating Officer, Vybe Urgent Care

Getting GLP-1s Approved:

End-to-End Prior Authorization for Obesity Programs

A 45-minute working session with the CEO of Neolytix and CMO of PrescriberPoint on improving first-pass approvals and shortening time-to-treatment.

Keynote Speakers

Raj Bhatnagar

Chief Executive Officer, Neolytix

Dr. Steve Strongwater
Chief Medical Officer, PrescriberPoint